Buprenorphine to reverse respiratory depression from methadone overdose in opioid-dependent patients: a prospective randomized trial
Abstract Background Naloxone is the usual drug used in opioid-induced respiratory depression but it has a short half-life, precipitates withdrawal in dependent patients, and thus for persistent reversal of long-acting opioids has to be given by titrated doses and infusions. The partial agonist bupre...
Main Authors: | Nasim Zamani, Nicholas A. Buckley, Hossein Hassanian-Moghaddam |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-02-01
|
Series: | Critical Care |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13054-020-2740-y |
Similar Items
-
Treatment retention in opioid agonist therapy: comparison of methadone versus buprenorphine/naloxone by analysis of daily-witnessed dispensed medication in a Canadian Province
by: Joseph Sadek, et al.
Published: (2022-07-01) -
Pharmacologic and Clinical Considerations of Nalmefene, a Long Duration Opioid Antagonist, in Opioid Overdose
by: Amber N. Edinoff, et al.
Published: (2021-10-01) -
Unspecified opioids among opioid overdoses in Oslo, Norway
by: Zahra Zeineb Iqbal, et al.
Published: (2022-04-01) -
Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic
by: David Dadiomov, et al.
Published: (2022-06-01) -
Comparison of 2 Naltrexone Regimens in the Maintenance Therapy of Acute Methadone Overdose in Opioid-Naïve Patients: A Randomized Controlled Trial
by: Ali Ostadi, et al.
Published: (2019-01-01)